ClinicalTrial Intelligence
🏠 Home
📊 Reports
🤖 AI Reports
LOGIN
Login
Sign up
Ensaios Clínicos (somente visualização)
Listagem completa dos ensaios clínicos importados do XML ICTRP.
Back
Id:
100
Trial ID:
RBR-5qcvv9
Public Title:
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients with Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Scientific Title:
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients with Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Scientific Title Native:
None
Recruitment Status:
recruitment completed
Study Type:
Intervention
Study Design:
3, randomized-controlled, double-blind
Study Phase:
3
Allocation:
None
Masking:
None
Purpose:
None
Date Registration:
2011-11-13
Date Enrolment:
2010-07-28
Last Refreshed:
None
Source Register:
None
Primary Sponsor:
Bristol-Myers Squibb
Secondary Sponsors:
Bristol-Myers Squibb
Web Address:
https://ensaiosclinicos.gov.br/rg/RBR-5qcvv9
Target Size:
None
Inclusion Criteria:
Metastatic prostate cancer. Asymptomatic or minimally symptomatic. Progression during hormonal therapy. ECOG Performance Status 0-1
Exclusion Criteria:
Liver, lung or brain metastases. Prior immunotherapy or chemotherapy for metastatic prostate cancer. Autoimmune disease. HIV, Hepatitis B, or Hepatitis C infection
Health Conditions:
None
Interventions Summary:
None
Contacts Summary:
None
Results:
None
Countries:
Updated On:
2026-06-01 05:16:33